WHO position statement on the use of delamanid for multidrug-resistant tuberculosis : Expedited review of the phase III clinical trial data of delamanid added to an optimised background MDR-TB regimen
Curatela
Data di Pubblicazione:
2018
Citazione:
WHO position statement on the use of delamanid for multidrug-resistant tuberculosis : Expedited review of the phase III clinical trial data of delamanid added to an optimised background MDR-TB regimen / World Health Organization; Moja L. ; [a cura di] W. Health Organization, L. Moja. - [s.l] : World Health Organization, 2018 Jan.
Tipologia IRIS:
06 - Curatela di volume
Elenco autori:
W. Health Organization, L. Moja
Link alla scheda completa: